Will a newborn contract herpes if the mother has an active herpes infection at the time of delivery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Herpes Transmission from Mother to Newborn

A newborn has a significant risk of contracting herpes if the mother has an active herpes infection at delivery, with transmission rates of 30-50% for primary infections and 0-5% for recurrent infections, but cesarean delivery substantially reduces this risk. 1, 2

Transmission Risk Factors

The risk of neonatal HSV infection varies significantly based on several key factors:

  • Type of maternal infection:

    • Primary (first episode) infection: 30-50% transmission risk 1
    • Recurrent infection: 0-5% transmission risk 1, 3
  • Timing of maternal infection:

    • Highest risk when infection is acquired near delivery 1, 3
    • Lower risk with established infections 1
  • Route of delivery:

    • Vaginal delivery with active lesions significantly increases risk 1, 3
    • Cesarean delivery reduces transmission by approximately 85% 3
  • Other risk factors:

    • Prolonged rupture of membranes (>6 hours) 1
    • Use of invasive procedures (e.g., fetal scalp monitoring) 1, 3
    • HSV-1 vs HSV-2 (HSV-1 has higher transmission risk) 3
    • Maternal age <21 years 3
    • Delivery before 38 weeks 3

Prevention Strategies

To prevent neonatal herpes infection when a mother has active herpes:

  1. Cesarean delivery:

    • Recommended for women with active genital lesions or prodromal symptoms at onset of labor 1, 2
    • Significantly reduces transmission risk from 7.7% to 1.2% when HSV is present 3
  2. Antiviral therapy:

    • For primary infections during pregnancy: Acyclovir 400 mg three times daily for 7-10 days 2
    • Suppressive therapy starting at 36 weeks' gestation for women with history of genital herpes:
      • Valacyclovir 500 mg twice daily OR
      • Acyclovir 400 mg three times daily 2
    • Reduces viral shedding, recurrences, and need for cesarean deliveries 2
  3. Preventive measures during pregnancy:

    • Avoid unprotected genital and oral sexual contact during late pregnancy 1, 2
    • Proper hand hygiene and avoiding direct contact with lesions 2

Neonatal Management

If a newborn is exposed to maternal HSV:

  • Immediate evaluation and treatment with IV acyclovir (20 mg/kg/dose three times daily) 2
  • Diagnostic workup including surface cultures/PCR, blood HSV PCR, CSF HSV PCR, and liver function tests 2
  • Treatment duration depends on disease classification:
    • Skin, Eye, Mouth (SEM) disease: 14 days 2
    • CNS or disseminated disease: 21 days 2

Important Caveats

  • Asymptomatic shedding: Even without visible lesions, HSV can be transmitted to the newborn 1
  • Congenital HSV: In-utero acquisition is rare but can cause devastating damage 1
  • HIV coinfection: Women with HIV/HSV coinfection have higher rates of HSV shedding (10% vs 2-3%) 1
  • Breastfeeding: Generally safe unless mother has cracked nipples with detectable HSV DNA 2

Despite preventive measures, neonatal HSV can still occur. Early recognition and prompt treatment are essential to reduce morbidity and mortality in affected infants.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Herpes Simplex Virus Infection During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.